An extra 229,000 deaths: Is that the cost of US-UK drugs deal?

Research finds that pharmaceutical trade deal requiring UK to buy more medicines from US takes away money from other parts of NHS, with deadly effects.

Save

Share

Research published in the British Medical Journal (BMJ) has found that a United Kingdom-United States pharmaceutical deal could cause 229,000 excess deaths as a result of the diversion of billions of pounds away from Britain’s National Health Service (NHS).

In December, the UK and US signed a pharmaceutical trade deal, under which the US government agreed not to impose tariffs on UK pharmaceutical and medical technology exports for the next three years.